Good Start Genetics Appoints Chief Executive Officer

Life sciences industry veteran Jeffrey Luber named president and CEO

Start Genetics®, Inc.
, a family genetics information solutions
company, announced today that it has appointed seasoned life sciences
industry executive, Jeffrey Luber, to the post of president and chief
executive officer (CEO). Luber has also been appointed to the Good Start
Genetics Board of Directors.

“I’m extremely proud of the talented team of professionals at Good Start
Genetics who have developed best-in-class products, processed more than
one million tests since the company’s inception and created a brand
synonymous with quality and better family health,” said Luber. “I look
forward to working closely with the team to leverage our strong
foundation and propel our future in existing and new markets.”

For two decades, Luber has been a life sciences executive in both public
and private companies. Prior to his appointment as CEO, Luber served as
Good Start Genetics’ general counsel and head of corporate development,
where he established a number of key relationships and new business
models central to the company’s growth in expanding markets. Previously,
Luber co-founded SynapDx, developer of blood-based technologies for the
early detection of autism. Luber also held several executive positions
at EXACT Sciences Corporation (NASDAQ: EXAS) including, president in
2007 and president and CEO from 2008-2009.

“Jeff’s business acumen, commitment to innovation and breadth of vision
are critical to leading Good Start Genetics through its next phase of
growth,” said Marc Beer, board chairman of Good Start Genetics. “Our
company is evolving quickly, growing in existing franchises as well as
new markets for the family. In addition, we are expanding in new ways
through patient-directed offerings, for which Jeff’s talents,
accomplishments and unique perspectives are particularly well-suited.”

“With the pace of genomic discovery increasing rapidly and families in
need of timely, reliable and consistent solutions for better
reproductive health, we are pleased to support Jeff in leading the
company through the next phase of growth,” said Carl Gordon, founding
partner and co-head of global private equity at OrbiMed. “Good Start
Genetics continues to expand its footprint in exciting new markets
through its steady launch of cutting edge products in clinical
sequencing, strong and innovative partnerships and market-leading
positioning. Jeff’s insights, leadership and experience will continue to
drive the company in providing information solutions to a variety of
stakeholders, both domestically and abroad.”

About Good Start Genetics®, Inc.
Good Start Genetics is an
information solutions company delivering best-in-class genetics
offerings to growing families. Using advanced clinical sequencing,
proprietary methods and information tailored to the individual, the
Company’s suite of offerings arm clinicians and patients with insightful
and actionable information to promote successful pregnancies and help
build healthy families. Its flagship genetic carrier screening service, GeneVu™,
is a comprehensive menu of highly-accurate tests for known and novel
mutations that cause inherited genetic disorders, and its proprietary
and advanced preimplantation genetic screening test, EmbryVu™,
based on technologies exclusively licensed from Johns Hopkins
University, is helping a wider range of couples find their paths to
pregnancy at significantly lower costs. Good Start Genetics complements
these offerings with world-class customer care and genetic counseling to
help families stay well-informed and best prepare for tomorrow. For more
information, please visit
or join us on Facebook,
and LinkedIn.


Racepoint Global
Jeff Stoecker, 617-624-3424